Trial Details

Not Recruiting
Basic Information
Clinical ID c3202
Identifier NL-OMON47738
Trial Title A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS - A3921139 (9002/009), OCTAVE Open Label
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions inflammatory bowel disease Ulcerative Colitis;10017969
Interventions Subjects will be assigned to one of two dose groups depending on their remission status at baseline of Study A3921139: Tofacitinib 5 mg BID (subjects in remission). Tofacitinib 10 mg BID (all other subjects).
Participant Information
Sponsor Pfizer
City -
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -